logo

SYK

Stryker·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

SYK fundamentals

Stryker (SYK) released its earnings on Oct 30, 2025: revenue was 6.06B (YoY +10.38%), beat estimates; EPS was 3.19 (YoY +11.15%), beat estimates.
Revenue / YoY
6.06B
+10.38%
EPS / YoY
3.19
+11.15%
Report date
Oct 30, 2025
SYK Earnings Call Summary for Q3,2025
  • Top Line Growth: 9.5% organic sales beat driven by Ortho (11.4%), Neuro (12.9%), and MedSurg (7.9%).
  • Margin Expansion: 25.6% adjusted operating margin, up 90bps YoY, with 200+ bps+ long-term target.
  • Acquisition Momentum: 2 tuck-in deals to strengthen surgical instruments, with Inari integration on track for 10%+ 2025 growth.
  • Tariff Risk: $200M full year impact, mostly in Q4, but no material impact to Q3 results.
  • Q4 Guidance: 9.8-10.2% organic growth, $13.50-13.60 EPS (vs. $13.35-13.55 prior).
EPS
Revenue

Revenue & Expenses

SYK has released its 2025 Q3 earnings report, with revenue of 6.06B, reflecting a YoY change of 10.25%, and net profit of 859.00M, showing a YoY change of 3.00%. The Sankey diagram below clearly presents SYK's revenue sources and cost distribution.

Key Indicators

Stryker (SYK) key financial stats and ratios, covering profitability, financial health, and leverage.
Stryker (SYK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Stryker (SYK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Stryker (SYK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Stryker (SYK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Stryker (SYK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield